Download presentation
Presentation is loading. Please wait.
Published byMargaret Webb Modified over 5 years ago
1
Surgical revascularization for coronary artery disease: are we about to surrender or cross the chasm? Hani Shennib, MD The Annals of Thoracic Surgery Volume 74, Issue 4, Pages (October 2002) DOI: /S (02)
2
Fig 1 Do you feel threatened by a decline in your cardiac surgery practice due to expansion of interventional cardiology practice? (1) Yes; (2) No. Number of respondents: 194. The Annals of Thoracic Surgery , DOI: ( /S (02) )
3
Fig 2 The greatest threat to surgical myocardial revascularization is: (1) catheter-based intervention (eg, angioplasty, stenting, atherectomy); (2) transmyocardial laser revascularization; (3) gene therapy (vascular endothelial growth factor, basic fibroblast growth factor); (4) governmental interference; (5) primary prevention (lipid lowering agents, smoking cessation programs). Number of respondents: 126. The Annals of Thoracic Surgery , DOI: ( /S (02) )
4
Fig 3 What percentage of CABG have you done by OPCAB technique in 2001? (1) <10%; (2) 10–25%; (3) 26–50%; (4) 51–75%; (5) 75–100%; (6) >100%. Number of respondents: 229. The Annals of Thoracic Surgery , DOI: ( /S (02) )
5
Fig 4 What percentage of CABG do you perform total arterial revascularization? (1) <10%; (2) 10–30%; (3) 31–50%; (4) 51–75%; (5) > 75%. Number of respondents: 301. The Annals of Thoracic Surgery , DOI: ( /S (02) )
6
Fig 5 Is a randomized controlled trial required to document the benefits of OPCAB and is such a trial feasible? (1) Yes; (2) No. Number of respondents: 139. The Annals of Thoracic Surgery , DOI: ( /S (02) )
7
Fig 6 Do you believe that robotic enhanced endoscopic cardiac surgery will reach a level of surgical routine? (1) in 2 years; (2) in 5 years; (3) in 10 years; (4) never. Number of respondents: 85. The Annals of Thoracic Surgery , DOI: ( /S (02) )
8
Fig 7 What do you think is the most limiting factor for adapting robotic-enhanced cardiac surgery? (1) insufficient robotic technology and instruments; (2) key hole access remains a problem; (3) patient lack of confidence; (4) cost is too steep; (5) lack of surgical training. Number of respondents: 82. The Annals of Thoracic Surgery , DOI: ( /S (02) )
9
Fig 8 If anastomotic devices become available to you, would you: (1) use them on all patients; (2) use them on selected patients; (3) not use them at all. Number of respondents: 168. The Annals of Thoracic Surgery , DOI: ( /S (02) )
10
Fig 9 Which of the following would make you use anastomotic devices: (1) speed of anastomosis; (2) consistent quality anastomosis; (3) decrease complication (stroke, aortic dissection); (4) enable access through small incision. Number of respondents: 172. The Annals of Thoracic Surgery , DOI: ( /S (02) )
11
Fig 10 What would not make you use anastomotic devices: (1) unproven patency rates; (2) cost; (3) device awkwardness; (4) limited application (selected grafts, aorta); (5) no reason not to use. Number of respondents: 171. The Annals of Thoracic Surgery , DOI: ( /S (02) )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.